Halozyme Therapeutics shares owned by Ing Investment Management
Quarter-by-quarter ownership of Halozyme Therapeutics shares owned by Ing Investment Management
from 13F filings
Historical chart of Ing Investment Management investment in Halozyme Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Halozyme Therapeutics held by Ing Investment Management consolidated in one spreadsheet with up to 7 years of data
Download as csvQuarterly reported holdings in Halozyme Therapeutics by Ing Investment Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-03-31 | $242M | 228M | 1.06 |
| 2024-12-31 | $202M | 211M | 0.96 |
| 2024-09-30 | $196M | 195M | 1.01 |
| 2024-06-30 | $182M | 190M | 0.96 |
| 2024-03-31 | $164M | 184M | 0.89 |
| 2023-12-31 | $160M | 184M | 0.87 |
| 2023-09-30 | $156M | 184M | 0.85 |
| 2023-06-30 | $157M | 187M | 0.84 |
| 2023-03-31 | $160M | 187M | 0.85 |
| 2022-12-31 | $228M | 234M | 0.97 |
| 2022-09-30 | $214M | 252M | 0.85 |